In this study, we analyzed the activation of bone-marrow derived dendritic cells (BMDCs) from mice lacking the cd14-gene with purified Legionella pneumophila lipopolysaccharide and with viable or formalin-killed L. pneumophila .We found that low concentrations of LPS and doses of L. pneumophila that are relevant to infection are dependent on CD14 to activate BMDCs. Higher concentrations of LPS are able to overcome the lack of CD14 indicating that other receptors are involved. We, therefore, included studies using BMDCs from mice lacking functional TLR2 and/or TLR4 molecules. We found that purified L. pneumophila LPS as well as L. pneumophila either viable or formalin-killed are able to activate BMDCs from TLR4-deficient C3H/HeJ mice but fail to activate BMDCs from TLR2-knockout mice. Our data show that not only purified LPS from L. pneumophila but also the microorganism itself stimulate BMDCs via TLR2 and that this stimulation is dependent on CD14 in this mouse model.
INTRODUCTION
Legionella pneumophila, the causative agent of Legionnaires' disease, is an intracellular pathogen of alveolar macrophages. Pneumonia primarily occurs in immunocompromized hosts suffering from malignancies associated with monocyte dysfunction as well as in patients who receive immunosuppressive drugs. The mechanism by which L. pneumophila infection of the lung is controlled is not yet clear. L. pneumophila is relatively resistant to innate and humoral immune response. The protective effect of antibody production and polymorphonuclear cells is limited [1] [2] [3] and activation of complement does not result in inactivation or killing of the bacteria. 4 Instead, cell-mediated immunity seems to be important for infection control. Initial investigations have demonstrated that lymphocytes from convalescents undergo proliferation and release cytokine activity into the cell culture supernatant after in vitro contact with formalin-inactivated legionellae. [5] [6] [7] [8] [9] The induction of cell-mediated immunity crucially depends on the participation of dendritic cells (DCs) as professional antigen-presenting cells (APCs) which are able to display processed antigens on MHC molecules. This was shown recently also for the presentation of L. pneumophila derived antigens. 10 In addition, upon first encounter with the pathogen, DCs are stimulated to mature and thereby to secrete pro-inflammatory cytokines. This is initiated by the recognition of conserved structures of the pathogen, the PAMPs (pathogen associated molecular patterns) by a set of pathogen recognition receptors (PRRs) such as Toll-like receptors (TLRs).
In this way, lipopolysaccharide (LPS) from the cell wall of Gram-negative bacteria triggers innate effector functions. Several molecules on the surface of innate immune cells are involved in this process. They include the LPS-binding protein (LBP), 11 which interacts with the GPI-anchored cell surface protein CD14, 12, 13 the signal transducing molecule TLR4 14 and the accessory molecule MD-2. 15 CD14 exists in two isoforms, the glycosylphosphatidylinositol (GPI) anchored membrane protein and the soluble serum protein 16 and both forms of CD14 can be involved in LPS signalling. 11 So far, the requirement for TLR4 is observed for all LPS types derived from bacteria belonging to the Enterobacteriaceae. However, recent studies have also shown that the LPS of some Gram-negative bacteria like Rhizobium and Legionella require TLR2 rather than TLR4. 17 In comparison with other Gram-negative bacteria, the lipopolysaccharide (LPS) of L. pneumophila exhibits unusual structural features 18, 19 which are predicted to be responsible for the interaction with TLR2 rather than with TLR4 molecules 7 and for the strongly reduced interaction with CD14 molecules on human monocytes. 20 The latter study revealed that about 1000-fold higher concentrations of L. pneumophila LPS (LPS-Lp) as compared to Escherichia coli (LPS-Ec) or Salmonella enterica serovar Minnesotaderived LPS (LPS-Sm) had to be used in order to achieve comparable cytokine production. This difference correlated with the inability of LPS-Lp to compete with LPS-Ec for the binding to membrane bound-CD14 and to interact with soluble CD14 molecules. Since competition and binding experiments are limited to a certain range of LPS concentrations that can be used, it remained to be determined whether or not weak and, therefore, so far undetectable interactions with CD14 molecules still take place and contribute to the LPS-Lp-mediated activation of cells of the innate immune system.
We, therefore, examined the contribution of CD14 and TLR molecules to the stimulation of bone marrowderived dendritic cells (BMDCs) by purified LPS-Lp as well as by viable or formalin-killed L. pneumophila using mice lacking CD14 molecules and different TLRs. Since LPS is the major pro-inflammatory constituent of the Gram-negative bacterial cell wall and is recognized by the host as main PAMP, we wondered whether intact bacteria are recognized by the same molecules as the purified LPS-Lp or if different TLRs are involved. We found for both purified LPS-Lp and intact bacteria that signal transduction involves CD14 molecules and strictly depends on TLR2 in our mouse model.
MATERIALS AND METHODS

Reagents and antibodies
LPS from Salmonella typhimurium (LPS-Stm) was purchased from Sigma-Aldrich (Taufkirchen, Germany). LPS from L. pneumophila serogroup 1 (LPS-Lp) was extracted according to Moll et al. 6 Phosphothioate-stabilized CpG oligonucleotide 1668 (TCC-ATC-ACG-TTC-CTG-ATG-C) (ODN) was obtained from TIB MOLBIOL (Berlin, Germany). Palmitoyl-3-Cys-Ser-(Lys)4 (Pam 3 Cys) was obtained from EMC microcollections GmbH (Tübingen, Germany).
Bacteria
L. pneumophila serogroup 1 strain Pontiac (isolated from a patient with severe Legionella pneumonia and passaged less than 3 times on BCYE α-agar) was kindly provided by Prof. Dr G Ruckdeschel (Munich, Germany).
Generation of mouse dendritic cells
Mouse immature DCs were generated from bone marrow of C3H/HeN, C3H/HeJ (Tularic Inc., South San Francisco, CA, USA), BALB/c (Charles River, Sulzfeld, Germany) and C3H/HeJ/TLR2 -/-, TLR2 -/-, CD14 -/mice as previously reported. 21 C3H/HeJ/TLR2 -/and TLR2 -/mice were generously provided by H. Wagner/K. Kirschning (Munich, Germany). CD14 -/mice were a kind gift from C. Schütt (Greifswald, Germany). For the generation of mouse bonemarrow derived DCs, Iscove's Modified Dulbecco's Medium (IMDM; BioWhittaker, Verviers, Belgium) was used supplemented with 2 mM L-glutamine (GibcoBRL Life Technologies, Paisley, UK), 100 IU/ml penicillin/streptomycin (GibcoBRL), 10% FCS (PAA, Linz, Austria) and 150 U/ml GM-CSF. Bone marrow cells from two mice were pooled and incubated in GM-CSF containing medium for 6-7 days and fresh medium with GM-CSF was replaced every 2 days. The obtained DCs were CD11c positive and CD14 negative.
Pre-treatment of mouse DCs prior stimulation
Immature DCs (6-7 days) derived from CD14 -/and B6 mice were washed 3 times with serum-free medium and were then stimulated either in the presence or absence of serum.
For stimulation with bacteria, bone marrow cells were washed on day 4 with antibiotic-free medium; for all further steps, antibiotic-free medium was used.
Stimulation of mouse DCs
Immature DCs were stimulated by addition of L. pneumophila LPS, S. typhimurium LPS, Pam 3 Cys or 1668 ODN in appropriate concentrations. For infection with L. pneumophila, the bacteria-to-cell ratio was adjusted to 10:1 and 1:1, respectively, using a 96-well tissue culture plate (Greiner, Frickenhausen, Germany). After 2 h of co-incubation at 37°C and 5% CO 2 , non-phagocytosed bacteria were killed by the addition of 75 µg/ml of gentamicin (Invitrogen, Eggenstein, Germany). After an additional incubation time of 20 h, supernatants were removed for detection of secreted cytokines.
Detection of mouse cytokines
Twenty hours after stimulation of mouse DCs, IL-6 and IL-12 (p40) concentrations in the cell culture supernatants were determined using standard sandwich ELISA protocols. Antibodies and recombinant cytokine standards were obtained from Becton Dickinson (Heidelberg, Germany). The capture antibody was bound to the ELISA plate (MaxiSorb™, Nunc, Roskilde, Denmark), the biotinylated detection antibody was visualized by streptavidin-conjugated horseradish peroxidase and TMB substrate (Sigma) and the assay was read at 405 nm.
RESULTS
BMDC activation by L. pneumophila LPS requires CD14
To investigate the role of CD14 during L. pneumophila LPS-induced activation, BMDCs derived from CD14 knockout mice and from BALB/c wild-type mice were stimulated with purified LPS from L. pneumophila in the presence or absence of FCS -which naturally contains soluble CD14 and LBP 12 -and cell culture supernatants Legionella pneumophila mediated activation of dendritic cells involves CD14 and TLR2 91 Fig. 1 . Role of CD14 in L. pneumophila LPS-mediated IL-6 production. Bone marrow-derived dendritic cells from the indicated mice strains were cultured with L. pneumophila LPS (10 µg/ml, 1 µg/ml or 100 ng/ml) in the presence and the absence of FCS -LPS of S. typhimurium (1 µg/ml, 100 ng/ml or 10 ng/ml) was used as CD14-dependent control and Pam 3 Cys (2.5 µg/ml) and polyI:C as CD14-independent control. After 20 h, the IL-6 concentration in the cell culture supernatants was measured by ELISA. (A) In the absence of FCS, BMDCs derived from CD14 knockout mice produced significantly less IL-6 in response to 100 ng/ml and 1 µg/ml of L. pneumophila LPS compared to the wild-type. (B) In the presence of FCS, the defect of CD14 is restored at concentrations higher than 1 µg/ml. The experiment was performed three times. The error bar represents the deviation of triplicates of one experiment.
were analyzed for the secretion of IL-6 ( Fig. 1 ) and IL-12 (data not shown).
Low concentrations of L. pneumophila LPS (e.g. < 1 µg/ml) activated BMDCs in a CD14-dependent manner.
Only higher concentrations of L. pneumophila LPS (10 µg/ml) activated BMDCs via a CD14-independent way. In the presence of FCS, BMDCs derived from CD14 knockout mice were more susceptible to activation by L. pneumophila LPS; however, at 100 ng/ml, BMDCs from CD14-knockout mice also produced reduced amounts of IL-6 ( Fig. 1B) . As a control for a CD14-dependent stimulation, LPS from S. typhimurium was used. As CD14-independent stimuli, Pam 3 Cys and polyI:C were added to BMDCs.
L. pneumophila interacts with CD14
To analyze the effect of CD14 under more physiological conditions and to elucidate whether additional CD14-independent stimuli play a role in BMDC activation, we used viable and formalin-killed bacteria instead of purified LPS. Both, viable and formalin-killed Legionella bacteria were able to stimulate BMDCs derived from wild-type mice to secrete IL-12 ( Fig. 2) and IL-6 (data not shown).
This stimulation was clearly CD14-dependent, since under serum-free conditions the ability of BMDCs derived from CD14-knockout mice to respond to L. pneumophila is drastically reduced. Addition of serum In the presence and the absence of FCS, bone marrow-derived dendritic cells from BALB/c and CD14 knockout mice were co-cultured with L. pneumophila at bacteria-to-cell ratios of 10:1 and 1:1. Non-phagocytosed bacteria were killed 2 h post-infection by addition of gentamicin. LPS of S. typhimurium (1 µg/ml, 100 ng/ml or 10 ng/ml) was used as CD14-dependent and Pam 3 Cys (2.5 µg/ml) and polyI:C as CD14-independent control. After 20 h, the supernatants were analysed for secretion of IL-12. (A) In the absence of FCS, the ability of BMDCs derived from CD14 knockout mice to secrete IL-12 in response to infection by viable or fixed L. pneumophila is impaired. (B) Addition of FCS to the cell culture restores the ability of BMDCs derived from CD14 knockout mice to secrete IL-12 in response to infection by viable or fixed L. pneumophila. The mean value of triplicates is shown together with the SD from one of three independent experiments. reconstitutes the ability of BMDCs to secrete cytokines partially. The controls were used as describe above.
L. pneumophila LPS triggers activation of BMDCs via TLR2 but not via TLR4
Since activation of BMDC by L. pneumophila LPS and Legionella bacteria requires the presence of CD14, we investigated whether Toll-like receptors (TLRs) are involved. To determine the role of TLRs, L. pneumophila LPS-mediated activation of BMDCs from mice lacking functional TLR2 and/or TLR4 molecules was studied. We investigated the secretion of the pro-inflammatory cytokines IL-12 ( Fig. 3 ) and IL-6 (data not shown) in response to L. pneumophila LPS, S. typhimurium LPS, Pam 3 Cys and CpG-ODN. BMDCs from C3H/HeN and C3H/HeJ (a TLR4-deficient mouse) but not from TLR2 -/and C3H/HeJ/TLR2 -/responded to the L. pneumophila LPS stimulus by secretion of IL-12. CpG-ODN induced IL-12 secretion in all cultures, Pam 3 Cys-mediated activation was abrogated in BMDCs from TLR2 -/mice and S. typhimurium LPS was impaired in BMDCs from C3H/HeJ mice, in line with previous reports.
BMDCs derived from TLR2 knockout mice do not respond to L. pneumophila
Since activation of BMDCs by L. pneumophila LPS was strictly dependent on TLR2 (Fig. 3) , we wanted to investigate if the activation of BMDCs by whole bacteria follows the same pathway. We, therefore, infected the above used BMDCs with viable and formalin-killed L. pneumophila and determined the secretion of IL-12. As shown in Figure 4 , BMDCs from wild-type mice (C3H/H3N) as well as from TLR4-deficient mice (C3H/HeJ) secreted IL-12 in response to the stimulation with L. pneumophila. In contrast, BMDCs from mice lacking TLR2 molecules (TLR2 -/and C3H/HeJ/TLR2 -/-) did not respond to the stimulation with L. pneumophila by secretion of IL-12. Oligonucleotide induced IL-12 secretion in all cultures, S. typhimurium LPS triggered activation via TLR4 (impaired activation in BMDCs from C3H/HeJ and C3H/HeJ/TLR2 -/mice) and Pam 3 Cys via TLR2 (impaired activation in BMDCs from TLR2 -/and C3H/HeJ/TLR2 -/mice), in line with previous reports. Interestingly, the fixation of L. pneumophila by 1% PFA seemed to be required to induce a strong activation of BMDCs.
DISCUSSION
It was assumed in the past that the LPS of enterobacteria is restricted to the use of TLR4 as a signal transducing molecule, whereas TLR2 is involved in the recognition of Gram-positive bacteria and Mycobacteria. 22, 23 However, it was recently demonstrated that even though Porphyromonas gingivalis, 24 Leptospira interrogans 25 and L. pneumophila 17 are Gram-negative bacteria, they activate cells of the immune system via a TLR2-dependent mechanism. Previous studies have also demonstrated that TLR4 Legionella pneumophila mediated activation of dendritic cells involves CD14 and TLR2 93 Fig. 3 . L. pneumophila LPS-induced IL-12 production by dendritic cells is TLR2 dependent. Bone marrow-derived dendritic cells from indicated mice strains were stimulated with L. pneumophila LPS (10 µg/ml, 1 µg/ml or 100 ng/ml), S. typhimurium LPS (100 ng/ml, 10 ng/ml or 1 ng/ml), Pam 3 Cys (2.5 µg/ml) and oligonucleotide 1668 (2.5 µM). After 20 h, the IL-12 concentration in the cell culture supernatants were measured by sandwich ELISA. Only BMDCs from C3H/HeN and C3H/HeJ mice secrete IL-12 in response to L. pneumophila LPS, BMDCs from TLR2 -/and C3H/HeJ/TLR2 -/mice do not. The mean value of triplicates from one of three independent experiments is shown. Error bars represent SD.
was not involved in host defense against pulmonary L. pneumophila infection. 26 Whereas TLR4-mediated responses to LPS require the presence of LBP and CD14 molecules, efficient TLR2-mediated signalling can also be observed in the absence of CD14. 27, 28 We, therefore, analyzed the contribution of TLR2, TLR4 and CD14 to the signaling pathways triggered by intact L. pneumophila and by its most abundant cell surface molecule LPS. For this purpose, we used BMDCs from mice lacking CD14 as well as mice with defects in TLR2 and TLR4. We found that both CD14 and TLR2 molecules are involved in the L. pneumophila LPS-induced secretion of pro-inflammatory cytokines by mouse BMDCs.
Although it has been recently demonstrated that the LPS of L. pneumophila does not interact with CD14 expressed by human monocytes, 20 we obtained the first evidence that CD14 might be involved in the activation of antigen-presenting cells by L. pneumophila LPS in a functional assay using BMDCs from CD14-knockout mice. Cytokine secretion induced by a low dose of LPS (1 µg/ml) was reduced in BMDCs from CD14 knockout mice, while high concentrations of LPS triggered BMDC activation also in the absence of CD14 (Fig. 1A) . The addition of serum containing sCD14 29 increased the ability of LPS to activate BMDCs even at low concentrations (Fig. 1B) .
The involvement of CD14 in the activation of APCs became clearly visible using live and fixed bacteria as a stimulus. At an infectious dose of 10:1 bacteria per cell BMDC, we observed a drastically reduced cytokine secretion in CD14 knockout mice compared to wild-type mice ( Fig. 2A) . It was not possible to test whether increased numbers of bacteria would provide a CD14independent stimulus as observed for L. pneumophila LPS because increasing the bacteria-to-cell ratio killed the BMDCs as observed previously. 30 As observed for purified L. pneumophila LPS, addition of serum induced a better cytokine secretion by BMDCs when intact bacteria were used for stimulation ( Fig. 2B ). In this case, BMDCs from CD14-knockout mice secreted the same amount of cytokines as the BMDCs from wild-type mice. However, in the absence of FCS, the ability of BMDCs from CD14-knockout mice to secrete cytokines is reduced compared to wildtype BMDCs ( Fig. 2A) .
We next investigated the role of TLRs in the activation of dendritic cells by L. pneumophila LPS and intact bacteria. Using BMDCs from C3H/HeJ, C3H/HeJ/TLR2 -/and TLR2 -/mice, we found that Legionella LPS triggered activation of BMDCs exclusively via TLR2 whereas TLR4 was not involved (Fig. 3 ). This finding was in line with the results obtained by Girard and col-94 Braedel-Ruoff, Faigle, Hilf et al. Fig. 4 . L. pneumophila activates dendritic cells to produce IL-12 via TLR2. L. pneumophila either viable or fixed by 1% PFA cells were added to the culture of BMDCs from the indicated mice strains in bacteria-to-cell ratios of 10:1 and 1:1. Two hours later, non-phagocytosed bacteria were killed by gentamicin. LPS from S. typhimurium (100 ng/ml), Pam 3 Cys (0.5 µg/ml) and oligonucleotide 1668 (0.5 µM) were used as controls. Cell culture supernatants were analysed after 20 h for the secretion of IL-12 by sandwich ELISA. BMDCs from C3H/HeN and C3H/HeJ mice are stimulated by both viable and fixed L. pneumophila to secrete IL-12. BMDCs from TLR2 -/and C3H/HeJ/TLR2 -/mice are not able to secrete IL-12 in response to neither viable nor fixed L. pneumophila. The mean value of triplicates from one of three independent experiments is shown. Error bars represent SD. leagues who described a TLR2-mediated CD14 expression in bone marrow derived granulocytes as a measurement for activation 17 and Kikuchi and colleagues reporting a TLR4-independent signaling of L. pneumophila LPS. 32 Our experiments extended this observation to intact bacteria: only TLR2 appeared to be involved in the Legionella-mediated activation of BMDCs without a detectable contribution of TLR4 (Fig.  4) . This absolute requirement for TLR2 in BMDC activation by whole bacteria was surprising since a redundant recognition of several different PAMPs (soluble or membrane bound) of a given pathogen was expected. However, our results strongly argue that LPS is the main structure for the recognition of L. pneumophila by the innate immune system. We can not finally rule out that other pathogen structures of L. pneumophila activate the immune system in a similar TLR2-and CD14-dependent manner although this might be quite unlikely. This finding is in contrast to the stimulation of innate immune responses by other bacteria like the Gram-positive group B streptococci (GBS). Here, a so far unknown secreted GBS factor stimulates macrophages in a CD14/TLR2/TLR6dependent manner but GBS stimulate cells without the contribution of these molecules. 31 Nevertheless, additional molecules might also influence the interaction of intact L. pneumophila with BMDCs. When we compared viable bacteria with bacteria killed by 1% PFA, we found that the latter were much more potent in activating BMDCs and inducing the secretion of cytokines ( Fig. 4) as reported recently. 32 This increase in BMDC activation is not due to the fixation procedure since irradiated bacteria behave like fixed bacteria (data not shown). Whether or not soluble factors secreted by live L. pneumophila which suppress the activation of cells of the innate immune system are involved remains to be determined.
CONCLUSIONS
These results provide strong evidence that L. pneumophila LPS is the main PAMP recognized on the surface of L. pneumophila and that CD14 contributes to TLR2-mediated activation.
